Bhavani Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-11-2024
- Paid Up Capital ₹ 1.00 M
as on 17-11-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.50 Cr
as on 17-11-2024
- Satisfied Charges ₹ 2.55 Cr
as on 17-11-2024
- Revenue 6.14%
(FY 2023)
- Profit 55.42%
(FY 2023)
- Ebitda 33.79%
(FY 2023)
- Net Worth 15.31%
(FY 2023)
- Total Assets 11.50%
(FY 2023)
About Bhavani Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.50 Cr. The company has closed loans amounting to ₹2.55 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nikunjkumar Modi, Nehalben Modi, Hasumatiben Modi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2008PTC055241
- Company No.
055241
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bhavani Pharmachem?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikunjkumar Modi  | Director | 14-Oct-2008 | Current |
| Nehalben Modi | Director | 14-Oct-2008 | Current |
| Hasumatiben Modi | Director | 24-Feb-2011 | Current |
| Mahendrabhai Kantilal | Director | 24-Feb-2011 | Current |
Financial Performance and Corporate Structure Insights of Bhavani Pharmachem.
Bhavani Pharmachem Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.14% increase. The company also saw a substantial improvement in profitability, with a 55.42% increase in profit. The company's net worth Soared by an impressive increase of 15.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhavani Pharmachem?
In 2023, Bhavani Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Harsh Biotech Private LimitedActive 17 years 7 monthsNikunjkumar Modi, Nehalben Modi and 2 more are mutual person
- Rajvi Biotech Private LimitedActive 17 years 7 months
Nikunjkumar Modi, Nehalben Modi and 2 more are mutual person
- Bhavani Medilink Private LimitedActive 6 years 9 months
Nikunjkumar Modi, Nehalben Modi and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 23 Apr 2024 | ₹9.50 Cr | Open |
Bank Of India Creation Date: 19 Nov 2018 | ₹0.80 M | Satisfied |
Others Creation Date: 27 Feb 2017 | ₹1.53 Cr | Satisfied |
How Many Employees Work at Bhavani Pharmachem?
Unlock and access historical data on people associated with Bhavani Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhavani Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhavani Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
